Stockscreener 앱 받기
55.43
4.37%
2.32
시간 외 거래:
55.41
-0.02
-0.04%
전일 마감가:
$53.11
열려 있는:
$53.15
하루 거래량:
12.76M
Relative Volume:
4.24
시가총액:
$13.02B
수익:
$4.03B
순이익/손실:
$789.50M
주가수익비율:
16.65
EPS:
3.33
순현금흐름:
$1.15B
1주 성능:
-4.76%
1개월 성능:
-9.53%
6개월 성능:
-30.09%
1년 성능:
-27.16%
1일 변동 폭
$52.81
$57.51
1주일 범위
$51.90
$57.93
52주 변동 폭
$51.90
$84.67
홀로직 Stock (HOLX) Company Profile
명칭
Hologic Inc
전화
(508) 263-2900
주소
250 CAMPUS DRIVE, MARLBOROUGH, MA
HOLX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
55.43 | 13.02B | 4.03B | 789.50M | 1.15B | 3.33 |
|
ISRG
Intuitive Surgical Inc
|
536.15 | 184.55B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
96.10 | 47.69B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.14 | 47.42B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
244.70 | 34.86B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
81.25 | 16.05B | 3.90B | 392.30M | 288.10M | 1.95 |
홀로직 Stock (HOLX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-03 | 다운그레이드 | Argus | Buy → Hold |
| 2025-02-06 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2025-02-03 | 다운그레이드 | Needham | Buy → Hold |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-10 | 개시 | Jefferies | Hold |
| 2024-12-10 | 재확인 | Needham | Buy |
| 2024-10-01 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-06-27 | 개시 | Stephens | Overweight |
| 2024-04-03 | 업그레이드 | Citigroup | Neutral → Buy |
| 2023-07-14 | 업그레이드 | Needham | Hold → Buy |
| 2022-12-07 | 개시 | RBC Capital Mkts | Sector Perform |
| 2022-10-13 | 개시 | Mizuho | Buy |
| 2022-07-20 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2022-07-20 | 개시 | UBS | Neutral |
| 2022-07-18 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2022-04-25 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-04-04 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2021-12-15 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-10-15 | 재개 | Cowen | Outperform |
| 2021-10-14 | 개시 | Redburn | Neutral |
| 2021-07-06 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2020-11-20 | 다운그레이드 | Needham | Buy → Hold |
| 2020-11-05 | 재확인 | Needham | Buy |
| 2020-06-30 | 업그레이드 | Cowen | Market Perform → Outperform |
| 2020-06-03 | 업그레이드 | Raymond James | Mkt Perform → Outperform |
| 2020-04-30 | 재확인 | Needham | Buy |
| 2020-04-30 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2020-04-07 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2020-03-27 | 업그레이드 | Morgan Stanley | Underweight → Equal-Weight |
| 2020-01-13 | 재확인 | Needham | Buy |
| 2020-01-08 | 개시 | Wells Fargo | Equal Weight |
| 2020-01-07 | 개시 | Citigroup | Buy |
| 2020-01-02 | 다운그레이드 | Evercore ISI | Outperform → In-line |
| 2019-09-26 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-08-01 | 재확인 | Needham | Buy |
| 2019-05-02 | 재확인 | Needham | Buy |
| 2019-01-31 | 재확인 | Needham | Buy |
| 2019-01-02 | 다운그레이드 | Morgan Stanley | Equal-Weight → Underweight |
| 2018-10-09 | 개시 | UBS | Neutral |
| 2018-09-13 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
모두보기
홀로직 주식(HOLX)의 최신 뉴스
Hologic: Soft Performance, But Cheap Enough (NASDAQ:HOLX) - Seeking Alpha
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo
Hologic outlines Q3 2025 revenue target of $1B-$1.01B amid breast health recovery - MSN
Four Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries - AboutLawsuits.com
Myomectomy Market Strengthens with Rise in Uterine Fibroid - openPR.com
Hologic (HOLX) Faces Lower Price Target Amidst Maintained Rating | HOLX Stock News - GuruFocus
Lobbying Update: $210,000 of HOLOGIC INC. lobbying was just disclosed - Nasdaq
Mizuho cuts Hologic stock price target to $65 from $75 By Investing.com - Investing.com Nigeria
Mizuho cuts Hologic stock price target to $65 from $75 - Investing.com
Hologic (HOLX) Price Target Reduced by Morgan Stanley Analyst | HOLX Stock News - GuruFocus
Morgan Stanley Cuts Price Target on Hologic to $65 From $77, Keeps Equalweight Rating - marketscreener.com
Hologic drops as tariffs and geopolitics lead to guidance cut - MSN
Hologic Second Quarter 2025 Earnings: EPS Misses Expectations - Yahoo Finance
Hologic, Inc. (NASDAQ:HOLX) Q2 2025 Earnings Call Transcript - Insider Monkey
Hologic stock price target cut to $65 by Jefferies - Investing.com South Africa
Breaking Down Hologic: 10 Analysts Share Their Views - Benzinga
Hologic Inc. stock underperforms Friday when compared to competitors - MarketWatch
Hologic (HOLX) Price Target Lowered by RBC Capital | HOLX Stock News - GuruFocus
Hologic (HOLX) Target Price Lowered by Raymond James | HOLX Stock News - GuruFocus
Hologic sees drop in sales and tariff impact on stock price - Radiology Business
Leerink Partners Adjusts Hologic Price Target to $60 From $65 - marketscreener.com
Jefferies Adjusts Hologic Price Target to $65 From $78 - marketscreener.com
Hologic Enters Oversold Territory (HOLX) - Nasdaq
Hologic falls after 2025 profit forecast cut - TradingView
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 - GuruFocus
Evercore ISI Group Lowers Price Target for Hologic (HOLX) to $62 | HOLX Stock News - GuruFocus
Hologic (HOLX) Shares Plunge 18% After Revised Earnings Outlook - GuruFocus
Hologic (HOLX): Price Target Reduced Amid Tariff Pressures | HOL - GuruFocus
Hologic (HOLX): Price Target Reduced Amid Tariff Pressures | HOLX Stock News - GuruFocus
RBC Cuts Price Target on Hologic to $70 From $75, Keeps Sector Perform Rating - marketscreener.com
Hologic (HOLX) Receives Hold Rating from Needham Analyst | HOLX Stock News - GuruFocus
Hologic stock drops after guidance cut (HOLX:NASDAQ) - Seeking Alpha
HOLOGIC INC SEC 10-Q Report - TradingView
Hologic Q2 Earnings & Revenues Top, '25 EPS View Lowered, Stock Down - Yahoo Finance
Hologic Inc (HOLX) Q2 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth - Yahoo Finance
Hologic shares fall 3% as Q2 guidance disappoints By Investing.com - Investing.com Nigeria
Hologic Inc (HOLX) Q2 Earnings: Revenue Hits $1,005.3M, Non-GAAP EPS at $1.03, Surpassing Estimates - GuruFocus
Hologic Exceeds Revenue Guidance Amid Challenges - TipRanks
Hologic: Fiscal Q2 Earnings Snapshot - MySA
Hologic Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Hologic Q2’25 slides: Mixed results amid long-term growth strategy - Investing.com India
Earnings call transcript: Hologic beats Q1 2025 EPS forecast amid stock dip - Investing.com Nigeria
Medical equipment maker Hologic lowers annual profit forecast on tariff uncertainty - TradingView
Hologic Posts Q2 Loss On Impairment Charges Despite Stable Revenue - Nasdaq
Hologic Announces Financial Results for Second Quarter of Fiscal 2025 - BioSpace
Hologic beats Q2 estimates, lowers full-year outlook By Investing.com - Investing.com South Africa
Hologic beats Q2 estimates, lowers full-year outlook - Investing.com
Hologic’s (NASDAQ:HOLX) Q1 Earnings Results: Revenue In Line With Expectations But Quarterly Revenue Guidance Significantly Misses Expectations - Yahoo Finance
Hologic (HOLX) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates - Yahoo
Hologic (HOLX) Tops Q2 Earnings and Revenue Estimates - Yahoo Finance
HOLOGIC Earnings Results: $HOLX Reports Quarterly Earnings - Nasdaq
홀로직 (HOLX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.49%
0.03%
자본화:
|
볼륨(24시간):